<DOC>
	<DOCNO>NCT01033357</DOCNO>
	<brief_summary>The purpose study determine whether long term use experimental Vascular Wrap ( TM ) Paclitaxel-Eluting Mesh safe treatment subject need hemodialysis access ( via expand polytetrafluoroethylene ( ePTFE ) graft ) .</brief_summary>
	<brief_title>Safety Study Vascular Wrap Paclitaxel-Eluting Mesh Hemodialysis Vascular Access</brief_title>
	<detailed_description>The primary objective study determine long term safety Lifespan® ePTFE Vascular Graft Vascular Wrap ( TM ) Paclitaxel-Eluting Mesh comparison Lifespan® graft alone .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>To consider enrollment , subject must : randomize protocol 012VWAV06 ; sign date IRBapproved write informed consent participate 012VWAV06 well study ; willing comply aspect evaluation schedule period 60 month post device insertion ; allow representative sponsor , designate Clinical Research Organization ( CRO ) , Institutional Review Board ( IRB ) , Ethics Committee , U.S. Food Drug Administration ( FDA ) review his/her relevant medical record . Subjects withdraw withdrawn study 012VWAV06 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>dialysis</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>neointimal hyperplasia</keyword>
</DOC>